semaglutide cardiovascular outcomes 2025 news A Lancet analysis of the SELECT trial concluded that reduced major adverse events by 20% in adults with overweight or obesity, regardless of how much weight patients actually lost Oral Semaglutide and Cardiovascular Outcomes

The logic behind this is simple: if you experience mild nausea or dizziness shortly after the injection, you might be able to sleep through the most uncomfortable part

The lactation study used injectable semaglutide and found undetectable milk levels

This ensures your complete medication regimen is reviewed for safety, particularly if you have multiple chronic conditions or take other prescription drugs that might interact with either semaglutide or acetaminophen

Tirzepatide is marketed as Mounjaro for type 2 diabetes and as Zepbound for chronic weight management and moderate-to-severe obstructive sleep apnea in adults with obesity